Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CVRx (CVRX) Cash & Equivalents (2020 - 2025)

CVRx (CVRX) has 6 years of Cash & Equivalents data on record, last reported at $75.7 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 28.53% year-over-year to $75.7 million; the TTM value through Dec 2025 reached $75.7 million, down 28.53%, while the annual FY2025 figure was $75.7 million, 28.53% down from the prior year.
  • Cash & Equivalents reached $75.7 million in Q4 2025 per CVRX's latest filing, down from $85.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $170.9 million in Q3 2021 and bottomed at $47.1 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $100.6 million, with a median of $100.2 million recorded in 2024.
  • The widest YoY moves for Cash & Equivalents: up 157.48% in 2022, down 35.65% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $142.1 million in 2021, then dropped by 25.25% to $106.2 million in 2022, then fell by 14.71% to $90.6 million in 2023, then rose by 16.96% to $105.9 million in 2024, then fell by 28.53% to $75.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $75.7 million in Q4 2025, $85.1 million in Q3 2025, and $95.0 million in Q2 2025.